Kyprolis carfilzomib regulatory update

FDA approved an sNDA from Amgen for Kyprolis carfilzomib to treat relapsed or refractory multiple myeloma (MM) in combination with dexamethasone or with Revlimid lenalidomide plus dexamethasone in pa...